A clear improvement on traditional treatment options, 3M™ Cavilon™ Advanced Skin Protectant is designed to deliver Incontinence-Associated Dermatitis (IAD) protection and prevention — even in the presence of continued incontinence. Cavilon Advanced Skin Protectant creates a highly durable, ultra-thin, transparent barrier that lasts up to seven days and doesn’t require removal, protecting patient skin like never before.
It protects your patients from caustic, corrosive body fluids1 without you losing sight of the condition of their skin.
It offers protection that flexes and stretches to significantly reduce frequency of reapplication.2
It provides waterproof,2 irritant-proof skin protection — even under the most challenging conditions.1
Robert Asmus is driven to create products that solve real-world issues. As lead scientist for 3M™ Cavilon™ Advanced Skin Protectant, he developed this game-changing skin barrier with the power to stop, reverse and prevent Incontinence-Associated Dermatitis (IAD).
3M chemists partnered with leading clinicians and Incontinence-Associated Dermatitis experts to develop Cavilon Advanced Skin Protectant. The results of clinical studies in two nursing care facilities speak for themselves.
Cavilon Advanced Skin Protectant may be transparent when applied, but the benefits of improved protection and prevention are quickly visible.
Learn what to look for when caring for patients at risk for IAD — and how to differentiate Incontinence-Associated Dermatitis from pressure ulcers or injuries.
Incontinence-Associated Dermatitis is a challenge in acute and long-term care settings. Learn more about the importance of maintaining the skin integrity of patients at risk for IAD.
1. Brennan MR, Milne CT, Agrell-Kann M, Ekholm BP. Clinical evaluation of a barrier film for the management of incontinence associated dermatitis (IAD) in an open label, non-randomized, prospective study. JWOCN 44(2):172-180, 2017.
2. 3M data on file. EM-05-013924.
3. Been R, Bernatchez SF, Conrad-Vlasak D, Asmus R, Eckholm B, Parks PJ. In vivo methods to evaluate a new skin protectant for loss of skin integrity. Wound Rep Regen 24(5):851-859, 2016. DOI: 10.1111/wrr.12455